Product Description

Berinert 500 : Presented as a powder and solvent for solution for injection/infusion.


  • Hereditary angioedema type I and II (HAE). Treatment and pre-procedure prevention of acute episodes.


  • Do not store above 30 C.
  • Do not freeze.
  • Keep the vial in the outer carton, in order to protect from light.

For storage conditions after reconstitution of the medicinal product

After reconstitution the physico-chemical stability of Berinert 500 has been demonstrated for 48 hours at room temperature (max. 30 °C). For Berinert 1500, the physico-chemical stability has been demonstrated for 48 hours at room temperature (max. 25 °C). From a microbiological point of view and as Berinert contains no preservative, the reconstituted product should be used immediately. If it is not administered immediately, storage shall not exceed 8 hours at room temperature. The reconstituted product should only be stored in the vial.


36 months from the date of manufacture

Virus safety

Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses.

1. India approved prescribing information for Berinert ® , February 2018   Medical code:IND-BRN-0012

Product Name

Berinert® 500

Generic Name

Human C1-esterase inhibitor

Strengths Available

500 IU

Pack shot is for illustrative purpose only. Locally registered pack may look different from image above